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Abstract
There is now strong evidence that surface contamination is linked to healthcare 
associated infections. Cleaning and disinfection should be sufficient to decrease 
microbial bioburden from surfaces in healthcare settings, and overall help in 
decreasing infections. It is however not necessarily the case. Evidence suggests 
there is a link between educational interventions and a reduction in infections. To 
improve the overall efficacy and appropriate usage of disinfectants, manufacturers 
need to engage with the end users in providing clear claim information and product 
usage instructions. This review provides a clear analysis of scientific evidence 
supporting the role of surfaces in healthcare associated infections, and the role of 
education in decreasing such infections. It is also looking at the debate opposing the 
use of cleaning vs. disinfection in healthcare settings. 
Keywords: cleaning, disinfection, antibiotic resistance, surface, HCAI 
Introduction 
Healthcare-associated infections (HCAIs) are defined as infections associated with 
interventions, devices or procedures carried out in healthcare facilities occurring in 
patients at the time of hospital admission or within 48 hours of admission [1,2]. In 
2011-2012 the European Centre for Disease Prevention and Control (ECDC) 
coordinated a Point Prevalence Survey (PPS) of HCAIs in acute care hospitals in 
Europe, the study revealed 6.0% of patients were infected with at least one HCAI, of 
which 54% were associated with a previous stay in the same hospital.  It is estimated 
on any given day 81,089 patients have a HCAI in Europe, with the most common 
HCAI associated with respiratory tract infections [2]. Non-device related infections 
might account for a significant proportion of HCAIs [2]. The most frequently reported 
microorganisms in HCAIs are Escherichia coli (15.9%), followed by Staphylococcus 
aureus (12.3%), Enterococcus spp. (9.6%), Pseudomonas aeruginosa (8.9%), 
Klebsiella spp. (8.7%), coagulase-negative staphylococci (7.5%) (see [2] for more 
details). While Clostridium difficile accounts only for 5.4%, it is responsible for 48% of 
all gastrointestinal infections.   
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It is conservatively estimated that HCAIs cost the NHS £1 billion annually (£3,154 
per patient) [1,3-5]. Significantly it is believed that 20-30% of HCAIs could be 
avoided with better application of existing knowledge and realistic infection control 
practices [4]. Enhanced cleaning practices are reported to save hospitals between 
£30,000–£70,000 [6]. With this in mind, infection prevention and control should be a 
priority at the forefront for all healthcare professionals and users, with a high 
standard of cleanliness being an intrinsic part of infection prevention.  With HCAIs, 
such as methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile and 
Norovirus, frequently reported in the media, infection control policies are subject to 
increased public scrutiny. Yet there appears to be a distinct lack of investment in the 
field of infection control, both from a research and product application perspective. 
This is also concurrent with a lack of understanding in disinfectant (biocidal product) 
efficacy and usage, which are often associated with, or lead to, poor practice. This 
review aims to analyse in more details the issues faced by infection control 
professionals and the industry. 
The unjustified controversy of cleaning/disinfection failing to impact on HCAIs
Until relatively recently, there was a belief that the hospital environment was not a 
source of transmission for HCAIs.  Indeed, early studies in the 1970s and 1980s 
indicated endemic transmission of pathogens via the hospital environment was 
negligible [7,8]. Since then a number of investigators have highlighted the 
importance of environmental contamination in the transmission of clinically relevant 
pathogens, such as C. difficile and MRSA [9-12] as well as the role of surface 
disinfection for controlling pathogenic microorganisms [13]. The importance of 
surface disinfection is further emphasised by its inclusion in several national and 
international infection control policies, including the epic3: national evidence-based 
guidelines for preventing healthcare-associated infections in NHS hospitals in 
England [14].  
Hospital setting, environmental persistence and transmission 
The most common source of microorganisms in a hospital setting are the patients 
themselves, infected and colonised patients (and hospital staff) shed bacteria, 
viruses and spores into the hospital environment.  Whilst a direct link between HCAIs 
and the presence of a microorganism on a hospital surface has not been established 
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[10,15-19], studies have reported many organisms responsible for HCAIs, including 
MRSA, C. difficile, norovirus and vancomycin-resistant enterococci, survive and 
persist on hospital surfaces at concentrations sufficient for transmission and 
transference to the hands of healthcare workers.  Given that the infectious dose for 
most potential pathogens appears to be low [20-22] coupled with the persistence of 
these organisms on hospital surfaces and medical equipment for prolonged periods 
(Table 1)[23], the presence of a pathogen on a surface does pose a transmission 
and/or infection risk (Table 2)[10-24]. 
In the hospital environment, areas near the patient and high-touch surfaces have 
been found to harbour microorganisms (Figure 1)[10,13,15,50,51]. A number of 
studies highlighted the transference of microorganisms from surfaces to hands 
(Table 3). Kampf and Kramer [61] reported the percentage of pathogens on 
healthcare workers hands as rhinovirus (65%), and rotavirus (19.5-78.6%), 
vancomycin-resistant enterococci (41%), Clostridium difficile (14-59%), Klebsiella
spp. (17%), MRSA (16.9%), Serratia marcescens (15.4-24%), Pseudomonas spp 
(1.3-25%) and Acinetobacter spp. (3-15%).  Adequate cleaning and/or disinfection of 
these surfaces (bedrails, commodes, doorknobs, light switches, patient call button, 
surfaces and equipment in close proximity to the patient) have been shown to be of 
particular importance [62-66]. It has been suggested that cleaning specifications do 
not adequately address high touch surfaces [10,50,67], with increased frequency 
and intensity of cleaning recommended for pathogens with an intestinal reservoir (C. 
difficile and norovirus)[68,69]. More recently, it has been suggested that cleaning 
and/or disinfection protocols should be ward specific and hence tailored to prevent 
ward-specific transmission routes. In addition to focusing on near patient surfaces, 
staff (medical chart, drug locker, staff toilet,) and patient (paper towel dispensers, bin 
lids) contact surfaces should also be considered as reservoirs of infection [70]. 
Evidence that surface decontamination eliminates transmission and lowers 
infection rates 
There is an increasing body of knowledge which highlights improved infection control 
practices can help break the chain of transmission [20,71,72]. A review was 
undertaken by Rutala and Weber [72] who recommended routine cleaning and 
disinfection of surfaces following a comprehensive review of epidemiological and 
5 
microbiological data following surface disinfection.  Studies which show a positive 
impact of environmental cleaning have focussed predominantly on MRSA, C. difficile
and norovirus, which is not surprising, given the infection rates and the ability of 
these organisms to persist in the environment (Table 4).   
Roles, responsibilities and education of healthcare workers 
The document compiled by the Comptroller and Auditor General on behalf of the 
National Audit Office [4] identified three staffing groups with cleaning responsibilities: 
a) dedicated cleaning staff, b) nursing, ambulance staff and departmental staff and c) 
estates staff. The division of cleaning responsibilities has often resulted in confusion, 
resulting in a number of objects (ward-based equipment) which ‘fall through the 
gaps” in the cleaning schedule [106,107]. With this in mind it is apt to refer to the 
Matron’s Charter which specifies that cleanliness is everyone’s responsibility, not just 
the cleaner’s [108]. Nonetheless it is evident that regular teaching of microbiological 
principles and infection control policies is beneficial [107,109]. 
Cleaning and disinfection form a fundamental part of infection control and 
prevention, integral to this is the appropriate education and training of all NHS 
personnel (medical and non-medical staff) and NHS users (patients and visitors).  
However, there appears to be a disparity in the provision of education and training 
provided to key healthcare personnel in the NHS.   Nurses and healthcare assistants 
were provided with induction training on infection control in 90% of NHS Trusts, 
whilst only 16% of senior doctors received training [4]. The importance of education 
and training is reinforced by evidence that they can contribute to reductions in HCAIs 
(Table 5).   
The education of healthcare workers may be hampered by the lack of general 
guidelines on cleaning standard and evaluation, and by conflicting information 
between the need for cleaning and/or disinfection and the evaluation of 
disinfectants/cleaning agents. There are no guidelines or standardised methods for 
monitoring of environmental cleaning.  Visual assessment is the most generally 
accepted measure of cleanliness [115,116], despite being an unreliable indicator of 
microbial contamination.  Currently the UK guidelines for surfaces in wards, is that 
they are “visually clean” [16]. A surface may be visibly free of soil however; this may 
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not reflect that the surface is free of microbial load. Visual assessments are the 
cheapest and quickest means of assessing cleanliness, providing an indication of 
personal performance and cleaning efficiencies.  However, subjective visual 
inspections have been reported to be poor indicators of cleanliness in comparison to 
fluorescent markers and adenosine triphosphate (ATP) assays [117].
UK guidelines do not currently advice on the routine sampling of floors, walls, 
surfaces and air [118]. Given that high touch surfaces are implicated in the 
transmission of HCAIs, validating and assessing the thoroughness of cleaning would 
be justified, serving as an additional training and educational tool. If sampling is to be 
undertaken the number of organisms per unit area or volume should be reported.  
Despite the time and resources required for microbial culturing, it represents the 
most accurate indication of the potential infection risk. The presence of indicator 
organisms, such as S. aureus, C. difficile, VRE or Acinetobacter spp., is indicative of 
a requirement for increased cleaning [119]. It has been proposed that aerobic colony 
counts on hand-touch sites should not exceed 2.5 CFU/cm2 [55,119-121]. 
Cleaning or disinfection? 
The choice of decontamination procedure will depend on the infection risk 
associated with the surface and the type of microorganism likely to have 
contaminated the surface [122,123]. An inherent consideration of all disinfection 
strategies is the elimination of the most resistant microbial sub-population. Yet there 
are disagreements about when and where a cleaning agent (removing of a 
bioburden from surfaces) or a disinfectant (killing microorganisms on surfaces) 
should be used (Table 6). This is further complicated by the fact that many 
disinfectant products will have a detergent (cleaning) ability too. In addition, there are 
many factors that will affect the efficacy of a disinfectants; these include factors 
related to the disinfectant such as concentration, pH and overall formulation, factors 
related to the target microorganisms and factors related to the product usage such 
as contact time, organic load, type of surface and temperature [124]. Failure to 
understand the effect of these factors on antimicrobial activity will result in the failure 
of the disinfectant. To assess the efficacy of a disinfectant a number of standard 
efficacy tests can be performed. These efficacy tests are key to product development 
and are the basis for regulatory clearance, labelling and use [125]. The type of test 
method employed and the requirements will depend on the type and intended 
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purpose of the microbicide (disinfection, preservation, and antisepsis) and its 
application (medical, agricultural, industrial). Although data from standardised 
efficacy test methods (e.g. European Norm tests) are required for a product to be 
commercialised and for a producer to make a product claim, the parameters used in 
these standard tests may not reflect realistic in-use conditions.  For example, 
disinfectants used in the healthcare settings generally have a contact time of 10 
minutes, i.e. the surface must stay wet after cleaning for 10 minutes to achieve a 3 
log reduction [13], however such a long exposure time is not practical and will 
require re-application of the product.  Generally the contact time specified on the 
label of a product is too long to reflect realistic in-use conditions, thus the efficacy of 
some products maybe grossly overestimated [125,126]. The Centres for Disease 
Control and Prevention (CDC) specifies a contact time of 3-5 minutes based on the 
evaporation of the product, however a 1 minute contact time is more realistic of in-
use conditions, indeed contact times of 30 – 60 seconds have been reported for a 
number of disinfectants [127-129]. For antimicrobial wipes, there is no international 
or national guidance on wipe selection and use [130,131]. Without an accepted 
standard test for wipes, information on the effectiveness of a product can only be 
gleaned from laboratory tests.  This can lead to the use of wipes that might not be 
appropriate for applications in the health care environment [132,133].
The choice of disinfectant will depend on its intended use, thus the manufacturer’s 
instructions should be followed to ensure correct application [124]. Incorrect 
selection and use of a formulated disinfectant can results in transference of 
microorganisms to clean surfaces [65,132,134-138]. In laboratory simulated 
conditions, studies have demonstrated the transference of microorganisms from 
contaminated cleaning cloths (commercial wipes and microfiber cloths) to clean 
surfaces [132,139,140]. Nine of the ten commercially available wipes tested 
demonstrated the repeated transfer of C. difficile spores [132]. The changing and/or 
cleaning of cloths and the wiping of surfaces from clean to dirty is crucial to limiting 
microbial transference [133].  
Conclusions 
A valid infection control intervention will reduce the microbial burden in the 
environment and hence the persistence of the organism, which can only be achieved 
with appropriate cleaning and disinfection programmes. As such surface disinfection 
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should be included in local, national and international infection control policies.  The 
current debate as to whether or not cleaning only (i.e. without a disinfection step) is 
sufficient to eliminate microbial pathogens from surfaces in the healthcare 
environment needs to be addressed and supported by practical evidence. 
It is clear that better education together with better compliance [141] of end users is 
needed. A number of considerations can easily be taken into account prior to 
choosing a disinfectant (Table 7). A product label will state the name of the test 
method used to assess the efficacy of the product.  Information relating to the test, 
the laboratory in which it was undertaken and the test results should be available 
from the manufacturer.
Concurrently, manufacturers need to have clear instructions about standard efficacy 
tests that need to be performed not only to make a product claim but also to 
represent better the usage of a product in practice. If no standard test is available, 
manufacturers should be encouraged to provide evidence of the activity of their 
products under in use conditions. Unfortunately, it is increasingly clear that a product 
that passes a standard efficacy test (such as European Norm tests) will meet its 
label claim but it might not necessarily mean that the product will be efficacious in 
practice; two of the most documented examples are the use of antimicrobial 
wipes130-133 or the testing of products against Clostridium difficile [142-144]. 
Manufacturers need also to provide clear product use instructions. Decreasing 
microbial bioburden on surfaces through cleaning and disinfection should be easily 
achievable with most of the disinfectant formulations available at present. More 
efforts need to be done to educate and motivate the end users to use the 
purposefully designed disinfectant appropriately. Decreasing HCAIs remain a 
multifactorial approach [145] in which surface decontamination is central [14].
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Table 1 Persistence of microorganisms on dry surfaces (based on [23]) 
Organism Persistence (range)
Acinetobacter spp 3 days to 5 months
Clostridium difficile (spores) 5 months
Enterococcus spp. including Vancomycin 
Resistant enterococci 
5 days – 4 months
Escherichia coli 1.5 hours – 16 months
Klebsiella spp. 2 hours to > 30 months
Mycobacterium tuberculosis 1 day – 4 months
Pseudomonas aeruginosa  6 hours – 16 months
Salmonella Typhimurium 10 days – 4.2 years
Shigella spp. 2 days – 5 months
Staphylococcus aureus, including MRSA 7 days – 7 months
Haemophilus influenzae 12 days
Adenovirus 7 days – 3 months
Influenza virus 1 – 2 days
Norovirus and feline calici virus (FCV) 8 hours – 7 days
Table 2 Evidence of persistence of microorganisms on surfaces and/or acquisition of 
infection from contaminated environment  
Evidence Organisms Reference
Plastic cover of medical charts are frequently 
contaminated with pathogens and may serve as source 
of infection
Coagulase-
negative 
staphylococci, 
MRSA, E. coli K. 
pneumoniae
and A. 
baumannii
[25]
24% of HCWs hands contaminated with C. difficile
spores after routine care of CDI patient. 44% of the
HCWs with contaminated hands provided at least one 
episode of direct patient care without use of gloves.
C. difficile [12]
79% of sampled surfaces were positive for MDROs. 
Molecular typing identified related strains from patients, 
the environment and hands of healthcare workers
MRSA, VRE, E. 
coli and K. 
pneumoniae
resistant to 
extended-
spectrum
cephalosporins, 
[26]
23 
and 
carbapenem-
resistant (CR) A. 
baumannii.
14% of clinical and emergency department rooms had 
≥1 surface contaminated with C. difficile. Outpatient 
clinics maybe an important source of community-
associated Clostridium difficile Infection (CDI)
C. difficile. [27]
15% of iPads sampled were positive for S. aureus S. aureus [28]
3% and 6% of hospital surfaces were contaminated 
with MRSA or C. difficile, respectively
MRSA, C. 
difficile
[29]
The persistence of potentially pathogenic staphylococci 
on hospital surfaces represents an infection threat
Staphylococci 
spp.
[30] 
Unrecognized colonization and/or the aerosolization of 
Enterococci together with inadequate cleaning can lead 
to widespread persistence in environmental 
contamination
Enterococci 
spp.
[31]
Environmental contamination due to C. difficile
aerosolisation can occur when a lidless toilet is flushed
C. difficile [32]
A prior room occupant with CDI is a significant risk 
factor for CDI acquisition. Of the patients who acquired 
CDI after admission 11% had a prior occupant with CDI
C. difficile [33]
60% of surfaces (gowns, bed rail/cranks, table and 
infusion pumps) in close proximity to patient were 
positive for MRSA and may serve as reservoirs for 
infection
MRSA [34] 
Bacterial contamination of stethoscopes ranges 
between 66-90% depending on site sampled (bells, 
earpieces and diaphragms). The presence of 
pathogenic and non-pathogenic bacteria on 
stethoscopes may pose a potential transmission risk
Micrococcus
spp., Coagulase 
negative staph, 
MRSA, MSSA, 
Pseudomonas
spp, 
Enterobacter 
spp., E. coli, 
Streptococcus 
viridans Group
[35]
24 
Toxin-producing C. difficile present in non-isolation 
rooms (16%), physician work areas (31%), nurses work 
station (10%) and portable equipment (21%)
C. difficile [36]
Acquisition of VRE from prior environmental
contamination of ICU
VRE [37]
Environmental contamination responsible for outbreak 
of A. baumannii
A. baumannii [38]
Increased risk of acquiring MRSA and VRE from rooms 
previously occupied by MRSA-positive and VRE-
positive patients
MRSA, VRE [39]
Enforced environmental cleaning reduces surface 
contamination with VRE
VRE [40]
Epidemiological link found between outbreak strains of 
Enterobacter cloacae and strains isolated from 
therapeutic beds
Enterobacter
cloacae
[41]
Widespread VRE contamination of surfaces and hands VRE [42]
Epidemiological link between hospital dust and 
transmission of MRSA
MRSA [43]
Presence of two toxigenic C. difficile in the environment 
accounted for 45.3% of CDAD cases 
C. difficile [44]
Outbreak strains survive longer than in the environment 
than non-outbreak strains
MRSA [45]
Survival and persistence of A. baumanii on dry 
surfaces
A. baumanii [46]
Survival and persistence of non-sporulating bacteria on 
dry surfaces
M. bovis, S. 
aureus, E. 
faecalis, S. 
thyphi, Ps. 
aeruginosa
[47]
Outbreak strains survive longer than in the environment 
than non-outbreak strains
MRSA [48]
Patient, HCW and environment implicated as source of 
C. difficile contamination
C. difficile [49] 
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Table 3 Evidence of transference of microorganisms onto hands of healthcare 
workers  
Comments Organisms Reference
24% of HCWs hands contaminated with C. 
difficile spores after routine care of CDI patient 
C. difficile [12]
39% of patients hands were contaminated with 
at least 1 pathogenic organism. Pathogenic 
organisms can be frequently detected on hands 
of acute care patients.
Acinetobacter spp.,
MRSA, C. difficile, VRE
[52]
Molecular typing identified related strains from 
patients, the environment and hands of HCWs
MRSA, VRE, E. coli and K. 
pneumoniae resistant to 
extended-spectrum
cephalosporins, and 
carbapenem-resistant (CR) 
A. baumannii.
[26]
Acquisition of C. difficile spores on gloved hand 
following contact with contaminated surfaces
C. difficile [24]
Daily disinfection of high-touch surfaces was 
associated with a significant reduction on 
pathogen acquisition on hands 
MRSA
C. difficile
[53]
A 10% risk of acquiring VRE is associated with 
each contact with VRE colonised patient and 
environment 
VRE [54]
23% of samples analysed did not meet hygiene 
standards, with hand touch sites found to 
display significantly more failures than non-hand 
touch sites
S. aureus
Aerobic colony counts
[55]
Transfer of VRE from inanimate objects and 
patient skin via hands of HCWs
VRE [56]
Environmental contamination is an important 
source of MDRO transmission 
MRSA, P. aeruginosa, 
Enterobacteriaceae, and A. 
baumannii
[57]
Evidence of transmission of influenza virus  
from objects to hands of healthcare workers
Influenza virus [58]
Transfer of VRE onto gloved hands after contact 
with contaminated surfaces.
VRE [59]
Surfaces in close proximity to patients are
frequently contaminated with MRSA. The 
contaminated surfaces may serve as a reservoir 
MRSA [60]
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of MRSA
Patient, HCW and environment implicated as 
source of C. difficile contamination 
C. difficile [49]
Table 4  Evidence that cleaning and disinfection eliminates transmission and lowers 
colonisation/infection rates 
Comments Organisms Reference
Surface disinfection reduced environmental 
contamination with VRE by 9%
VRE [73] 
Cleaning and disinfection of respiratory equipment with 
70% ethanol wipe reduced fungal and bacterial 
contamination by 60% and 75%, respectively
Pseudomonas spp.
Acinetobacter spp., 
Klebseilla 
pneumoniae, E.coli
and 
Stenotrophomonas 
maltophila. Candida 
spp, Streptomyces 
spp, Aspergillus
[74] 
Daily disinfection of high touch surfaces and a 
dedicated housekeeping team resulted in a 60% 
reduction in the number of C. difficile positive cultures
C. difficile [75] 
Disinfection of portable ultrasound machines with 
isopropanol reduced contamination by 85%
Coagulase negative 
staphylococcus spp., 
Neisseria spp., 
Streptococcus spp.
[76] 
Cleaning with a hydrogen peroxide disinfectant wipe 
yielded <2.5 CFU/cm2 on 99% of surfaces
Aerobic colony count [77]
37% reduction in CDAD rate was observed following
HPV decontamination
C. difficile [78] 
Hydrogen peroxide vapour (VHP) decontamination of 
rooms reduced the likelihood of MDROs and VRE 
acquisition by 64% and 80% respectively
VRE, multidrug 
resistant Gram-
negatives
[79] 
Environmental cleaning, education, hand hygiene and 
VHP decontamination successfully controlled MRAB in 
an intensive therapy unit
A. baumannii [80]
Antibacterial wipes reduce the numbers of bacteria S. aureus [81]
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near to the patient
Early intensification of infection control practices 
(disinfection, hand hygiene and education) interrupts 
the transmission of carbapenemase-producing 
Klebsiella pneumoniae outbreak
K. pneumoniae [82] 
Disinfection of bed rails reduced the intrinsic bacterial 
burden by up to 99%
Staphylococci spp.
VRE
[83]
Active surveillance and adherence to infection control 
procedures required to prevent transmission of VRE
VRE [84] 
Patients with MDR-AB, frequently contaminate the 
environment.  Surfaces often touched by health care 
workers are commonly contaminated and may facilitate 
transmission
A. baumannii [85] 
Daily disinfection with a germicidal bleach wipe reduced 
hospital acquired-CDAD by 85%
C. difficile [86] 
Use of disinfectant wipes on  supports used in hip 
arthroplasty may reduce infection rates
Coagulase negative 
staphylococci, 
coryforms, Bacilli spp.
[87] 
Enhanced ICU cleaning may reduce VRE and MRSA 
transmission and acquisition
VRE, MRSA [88] 
Environmental decontamination using VHP halted the 
transmission of MDR A. baumannii in a long term acute 
care hospital
MDR A. baumanii [89] 
Enhanced cleaning reduced microbial contamination of 
high-risk hand-touch sites by 32.5% and MRSA 
infections by 26.6%
MRSA [10]
39% reduction in CDAD rate was observed following 
HPV decontamination.  When adjusted for presence of 
epidemic NAP1 strain a 53% reduction in CDAD rate.
C. difficile [90]
Changes to cleaning protocols reduced environmental 
contamination with gastroenteric viruses
Norovirus, astrovirus, 
rotavirus
[91]
Patient and staff decolonisation combined with HPV 
decontamination terminated MRSA outbreak on 
surgical ward
MRSA [92] 
Cleaning with water and detergent followed by cleaning 
with hypochlorite helps to achieve a greater reduction in 
Aerobic count, MRSA [93] 
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the total bacterial bio-burden on hand touch sites in 
isolation rooms
Environmental cleaning with sodium hypochlorite
solution reduced rate of CDAD 
C. difficile [94] 
Implementation of appropriate control measures 
controlled C. difficile outbreak 
C. difficile [95]
Epidemiological link found between outbreak strains of 
Enterobacter cloacae and strains isolated from 
therapeutic beds
Enterobacter cloacae [41]
Increased cleaning reduced environmental 
contamination of VRE 
VRE [40]
Thorough cleaning and HPV disinfection eradicated 
Serratia marcescens from a neonatal intensive care 
unit (NICU)
Serratia marcescens [96]
Transfer of VRE from inanimate objects and patient 
skin via hands of HCWs
VRE [56]
Environmental contamination is an important source of 
transmission of nosocomial pathogens 
MRSA, P. 
aeruginosa, 
Enterobacteriaceae, 
and A. baumannii
[57]
Significant correlation between environmental 
contamination and patient colonisation/infection with A. 
baumanii
A. baumannii [97] 
Thorough environmental cleaning and education can 
reduce transmission of  A. baumanii
A. baumannii [98] 
Cleaning with hypochlorite significantly reduced 
incidence of CDI on one ward
C. difficile [99] 
Environmental decontamination with 0.5% sodium 
hypochlorite attributed to control of VRE outbreak
VRE [100]
Routine and thorough cleaning contributed to the 
control of MRSA outbreak
MRSA [43]
Hand washing, environmental cleaning and disinfecting 
may help reduce infection rate in long-term care 
facilities
- [101]
Barrier precautions and environmental decontamination VRE [102] 
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eradicated VRE outbreak
Environmental disinfection with sodium hypochlorite 
reduced rates of CDAD
C. difficile [103] 
Environmental contamination by MRSA can be 
controlled by supervised cleaning and education
MRSA [104] 
Aggressive infection control measures (included 
environmental disinfection, hand washing, education) 
resulted in sustained decrease in CDI over 7 year 
period
C. difficile [105] 
Table 5 Evidence that education and training reduces environmental contamination  
Comments References
The use of fluorescent markers resulted in a 10% reduction in the 
number of positive CDI cultures after disinfection
[76]
Daily disinfection of iPads with isopropanol wipes following app based 
instructions reduced microbial load 
[110]
Gram staining of environmental cultures and use of UV markers was 
successful at improving cleaning in operating rooms
[111]
Improved cleaning practices, staff education, and monitoring cleanliness 
reduced environmental prevalence of MRSA and VRE in ICU rooms.
[112] 
Educational interventions directed at housekeeping staff reduced C. 
difficile and VRE contamination of surfaces
[113] 
Implementation of appropriate control measures controlled CDI outbreak [95] 
Educating health-care workers and families of patients, and all head 
nurses contributed to controlling outbreak of C. difficile
[114] 
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Table 6 Summary for and against the use of detergents and disinfectants (modified 
from Rutala and Weber [72] 
Justification for detergent use Justification for disinfection use
Surfaces contribute minimally to endemic 
nosocomial infections 
Surfaces may contribute to the transmission 
of epidemiologically important microbes (e.g., 
VRE, MRSA, C. difficile, viruses)
There is no difference in infection rates of 
floors cleaned with detergent versus 
disinfectant
Disinfectants are needed for surfaces 
contaminated by blood and other potentially 
infective material 
No environmental impact associated with 
disposal of detergents
Disinfectants are more effective than 
detergents in reducing microbial load on floors 
Lower costs Detergents become contaminated and result 
in seeding the patient’s environment with 
bacteria 
No occupational health exposure issues Some newer disinfectants have persistent 
antimicrobial activity 
Use of antiseptics/disinfectants may select
for antibiotic-resistant bacteria, especially 
where a residual activity is present
Advantage of using a single product for 
decontamination of floors and equipment
More aesthetically pleasing floor Formulations can achieve a combination of 
cleaning and disinfection, while resulting in 
aesthetically pleasing floor
Disinfectants may reduce the risk of emerging 
bacterial resistance
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Table 7 Evaluating efficacy testing data for surface disinfection 
Questions Comments
What standardised test was used? Test used appropriate to make a claim for 
healthcare application?
A phase 2 step 2 test should be used♯ (i.e. 
surface test)
Does it support the application claim? Bactericidal, sporicidal, fungicidal
For sporicidal claim: what bacterial species 
was used?
Was the exposure time realistic? A contact time of 5, 10 and >10 min for 
surface disinfection is not realistic (see text)
Was the test conducted in clean (0.3 g/L 
bovine serum albumin) or dirty conditions 
(3.0 g/L bovine serum albumen♯)? 
Absence of test with organic load limits the 
practicability of the test.
Was a neutralisation step used? Absence of neutralisation increases the 
apparent activity of a disinfectant*
Was C. difficile used? Need to have information on spore 
production method and purity level of the 
preparation (>90% spores).
Need to have assurance test laboratory has 
access to anaerobic facility.
Were controls performed? For specific activity, for example sporicidal 
activity, a hypochlorite control can be used to 
validate the appropriateness of the test 
method.
♯ for European Norm test 
* European Norm test include neutraliser, and controls of neutraliser toxicity and 
efficacy. 
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Figure 1: Examples of high touch surfaces found to harbour microorganisms in the 
healthcare setting. (1) bed frame and cot sides, (2) bed controls, (3) light 
switch, (4) patient chair, (5) mattress, (6) tray table, (7) bedside table, (8) 
IV pole, (9) IV pump, (10) patient entertainment system and nurse call 
button 
